Thermo Fisher Scientific Q2 2024 Adj EPS $5.37 Beats $5.12 Estimate, Sales $10.540B Beat $10.511B Estimate
Portfolio Pulse from Benzinga Newsdesk
Thermo Fisher Scientific (NYSE:TMO) reported Q2 2024 adjusted EPS of $5.37, beating the estimate of $5.12. Sales were $10.540 billion, slightly above the $10.511 billion estimate but down 1.38% from last year.
July 24, 2024 | 10:00 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Thermo Fisher Scientific reported better-than-expected Q2 2024 earnings and sales, although sales were down 1.38% year-over-year.
Thermo Fisher Scientific's Q2 2024 earnings and sales both exceeded analyst expectations, which is likely to have a positive short-term impact on the stock price. However, the slight year-over-year decline in sales may temper some of the enthusiasm.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100